TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAs

Transforming growth factor-β1 (TGF-β1) has an essential role in the development of kidney diseases. However, targeting TGF-β1 is not a good strategy for fibrotic diseases due to its multifunctional characteristic in physiology. A precise therapeutic target maybe identified by further resolving the u...

Full description

Saved in:
Bibliographic Details
Published in:Non-coding RNA research 2017-03, Vol.2 (1), p.68-73
Main Authors: Tang, Patrick Ming-Kuen, Tang, Philip Chiu-Tsun, Chung, Jeff Yat-Fai, Lan, Hui-Yao
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3741-51a146f38ef41b542cd2cfeed3c22045106b039964e34f94a7ea94ab017675413
cites cdi_FETCH-LOGICAL-c3741-51a146f38ef41b542cd2cfeed3c22045106b039964e34f94a7ea94ab017675413
container_end_page 73
container_issue 1
container_start_page 68
container_title Non-coding RNA research
container_volume 2
creator Tang, Patrick Ming-Kuen
Tang, Philip Chiu-Tsun
Chung, Jeff Yat-Fai
Lan, Hui-Yao
description Transforming growth factor-β1 (TGF-β1) has an essential role in the development of kidney diseases. However, targeting TGF-β1 is not a good strategy for fibrotic diseases due to its multifunctional characteristic in physiology. A precise therapeutic target maybe identified by further resolving the underlying TGF-β1 driven mechanisms in renal inflammation and fibrosis. Smad signaling is uncovered as a key pathway of TGF-β1-mediated renal injury, where Smad3 is hyper-activated but Smad7 is suppressed. Mechanistic studies revealed that TGF-β1/Smad3 is capable of promoting renal inflammation and fibrosis via regulating non-coding RNAs. More importantly, involvement of disease- and tissue-specific TGF-β1-dependent long non-coding RNAs (lncRNA) have been recently recognized in a number of kidney diseases. In this review, current understanding of TGF-β1 driven lncRNAs in the pathogenesis of kidney injury, diabetic nephropathy and renal cell carcinoma will be intensively discussed.
doi_str_mv 10.1016/j.ncrna.2017.04.001
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6096420</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2468054016300154</els_id><sourcerecordid>2097591433</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3741-51a146f38ef41b542cd2cfeed3c22045106b039964e34f94a7ea94ab017675413</originalsourceid><addsrcrecordid>eNp9kc1qGzEUhUVoSUyaJwiEWXYzk6uf0XgKLQRTO4WQQH7WQpbuuHJnJFeyDXmtPkieKXKdhHTTjSTQd86VziHklEJFgcrzZeVN9LpiQJsKRAVAD8iICTkuoRbw4d35iJyktIRMjJmUUhySIw60bgVjIzK7n03Lpz-0SG7hde_8onC--OWsx8fCuoQ64ZdiGsNQ3A3apmIdij5kygdfmmB3gtvri_SJfOx0n_DkZT8mD9Pv95PL8upm9mNycVUa3gha1lRTITs-xk7QeS2Yscx0iJYbxkDUFOQceNtKgVx0rdAN6rzO8y9lUwvKj8m3ve9qMx_QGvTrqHu1im7Q8VEF7dS_N979VIuwVRKyKYNs8PnFIIbfG0xrNbhksO-1x7BJikHb1C0VnGeU71ETQ0oRu7cxFNSuBbVUf1tQuxYUCJUzzqqz9y9807xmnoGvewBzTluHUSXj0Bu0LqJZKxvcfwc8A6rZmF8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2097591433</pqid></control><display><type>article</type><title>TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAs</title><source>ScienceDirect Journals</source><source>PubMed Central</source><creator>Tang, Patrick Ming-Kuen ; Tang, Philip Chiu-Tsun ; Chung, Jeff Yat-Fai ; Lan, Hui-Yao</creator><creatorcontrib>Tang, Patrick Ming-Kuen ; Tang, Philip Chiu-Tsun ; Chung, Jeff Yat-Fai ; Lan, Hui-Yao</creatorcontrib><description>Transforming growth factor-β1 (TGF-β1) has an essential role in the development of kidney diseases. However, targeting TGF-β1 is not a good strategy for fibrotic diseases due to its multifunctional characteristic in physiology. A precise therapeutic target maybe identified by further resolving the underlying TGF-β1 driven mechanisms in renal inflammation and fibrosis. Smad signaling is uncovered as a key pathway of TGF-β1-mediated renal injury, where Smad3 is hyper-activated but Smad7 is suppressed. Mechanistic studies revealed that TGF-β1/Smad3 is capable of promoting renal inflammation and fibrosis via regulating non-coding RNAs. More importantly, involvement of disease- and tissue-specific TGF-β1-dependent long non-coding RNAs (lncRNA) have been recently recognized in a number of kidney diseases. In this review, current understanding of TGF-β1 driven lncRNAs in the pathogenesis of kidney injury, diabetic nephropathy and renal cell carcinoma will be intensively discussed.</description><identifier>ISSN: 2468-0540</identifier><identifier>EISSN: 2468-0540</identifier><identifier>DOI: 10.1016/j.ncrna.2017.04.001</identifier><identifier>PMID: 30159422</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><ispartof>Non-coding RNA research, 2017-03, Vol.2 (1), p.68-73</ispartof><rights>2017 The Authors</rights><rights>2017 The Authors 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3741-51a146f38ef41b542cd2cfeed3c22045106b039964e34f94a7ea94ab017675413</citedby><cites>FETCH-LOGICAL-c3741-51a146f38ef41b542cd2cfeed3c22045106b039964e34f94a7ea94ab017675413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096420/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2468054016300154$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3548,27923,27924,45779,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30159422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tang, Patrick Ming-Kuen</creatorcontrib><creatorcontrib>Tang, Philip Chiu-Tsun</creatorcontrib><creatorcontrib>Chung, Jeff Yat-Fai</creatorcontrib><creatorcontrib>Lan, Hui-Yao</creatorcontrib><title>TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAs</title><title>Non-coding RNA research</title><addtitle>Noncoding RNA Res</addtitle><description>Transforming growth factor-β1 (TGF-β1) has an essential role in the development of kidney diseases. However, targeting TGF-β1 is not a good strategy for fibrotic diseases due to its multifunctional characteristic in physiology. A precise therapeutic target maybe identified by further resolving the underlying TGF-β1 driven mechanisms in renal inflammation and fibrosis. Smad signaling is uncovered as a key pathway of TGF-β1-mediated renal injury, where Smad3 is hyper-activated but Smad7 is suppressed. Mechanistic studies revealed that TGF-β1/Smad3 is capable of promoting renal inflammation and fibrosis via regulating non-coding RNAs. More importantly, involvement of disease- and tissue-specific TGF-β1-dependent long non-coding RNAs (lncRNA) have been recently recognized in a number of kidney diseases. In this review, current understanding of TGF-β1 driven lncRNAs in the pathogenesis of kidney injury, diabetic nephropathy and renal cell carcinoma will be intensively discussed.</description><issn>2468-0540</issn><issn>2468-0540</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc1qGzEUhUVoSUyaJwiEWXYzk6uf0XgKLQRTO4WQQH7WQpbuuHJnJFeyDXmtPkieKXKdhHTTjSTQd86VziHklEJFgcrzZeVN9LpiQJsKRAVAD8iICTkuoRbw4d35iJyktIRMjJmUUhySIw60bgVjIzK7n03Lpz-0SG7hde_8onC--OWsx8fCuoQ64ZdiGsNQ3A3apmIdij5kygdfmmB3gtvri_SJfOx0n_DkZT8mD9Pv95PL8upm9mNycVUa3gha1lRTITs-xk7QeS2Yscx0iJYbxkDUFOQceNtKgVx0rdAN6rzO8y9lUwvKj8m3ve9qMx_QGvTrqHu1im7Q8VEF7dS_N979VIuwVRKyKYNs8PnFIIbfG0xrNbhksO-1x7BJikHb1C0VnGeU71ETQ0oRu7cxFNSuBbVUf1tQuxYUCJUzzqqz9y9807xmnoGvewBzTluHUSXj0Bu0LqJZKxvcfwc8A6rZmF8</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Tang, Patrick Ming-Kuen</creator><creator>Tang, Philip Chiu-Tsun</creator><creator>Chung, Jeff Yat-Fai</creator><creator>Lan, Hui-Yao</creator><general>Elsevier B.V</general><general>KeAi Publishing</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170301</creationdate><title>TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAs</title><author>Tang, Patrick Ming-Kuen ; Tang, Philip Chiu-Tsun ; Chung, Jeff Yat-Fai ; Lan, Hui-Yao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3741-51a146f38ef41b542cd2cfeed3c22045106b039964e34f94a7ea94ab017675413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tang, Patrick Ming-Kuen</creatorcontrib><creatorcontrib>Tang, Philip Chiu-Tsun</creatorcontrib><creatorcontrib>Chung, Jeff Yat-Fai</creatorcontrib><creatorcontrib>Lan, Hui-Yao</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Non-coding RNA research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Patrick Ming-Kuen</au><au>Tang, Philip Chiu-Tsun</au><au>Chung, Jeff Yat-Fai</au><au>Lan, Hui-Yao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAs</atitle><jtitle>Non-coding RNA research</jtitle><addtitle>Noncoding RNA Res</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>2</volume><issue>1</issue><spage>68</spage><epage>73</epage><pages>68-73</pages><issn>2468-0540</issn><eissn>2468-0540</eissn><abstract>Transforming growth factor-β1 (TGF-β1) has an essential role in the development of kidney diseases. However, targeting TGF-β1 is not a good strategy for fibrotic diseases due to its multifunctional characteristic in physiology. A precise therapeutic target maybe identified by further resolving the underlying TGF-β1 driven mechanisms in renal inflammation and fibrosis. Smad signaling is uncovered as a key pathway of TGF-β1-mediated renal injury, where Smad3 is hyper-activated but Smad7 is suppressed. Mechanistic studies revealed that TGF-β1/Smad3 is capable of promoting renal inflammation and fibrosis via regulating non-coding RNAs. More importantly, involvement of disease- and tissue-specific TGF-β1-dependent long non-coding RNAs (lncRNA) have been recently recognized in a number of kidney diseases. In this review, current understanding of TGF-β1 driven lncRNAs in the pathogenesis of kidney injury, diabetic nephropathy and renal cell carcinoma will be intensively discussed.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>30159422</pmid><doi>10.1016/j.ncrna.2017.04.001</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2468-0540
ispartof Non-coding RNA research, 2017-03, Vol.2 (1), p.68-73
issn 2468-0540
2468-0540
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6096420
source ScienceDirect Journals; PubMed Central
title TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A49%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TGF-%CE%B21%20signaling%20in%20kidney%20disease:%20From%20Smads%20to%20long%20non-coding%20RNAs&rft.jtitle=Non-coding%20RNA%20research&rft.au=Tang,%20Patrick%20Ming-Kuen&rft.date=2017-03-01&rft.volume=2&rft.issue=1&rft.spage=68&rft.epage=73&rft.pages=68-73&rft.issn=2468-0540&rft.eissn=2468-0540&rft_id=info:doi/10.1016/j.ncrna.2017.04.001&rft_dat=%3Cproquest_pubme%3E2097591433%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3741-51a146f38ef41b542cd2cfeed3c22045106b039964e34f94a7ea94ab017675413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2097591433&rft_id=info:pmid/30159422&rfr_iscdi=true